CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
======================================================================================================================================================================================================

* Niklas Klümper
* Damian J Ralser
* Romina Zarbl
* Katrin Schlack
* Andres Jan Schrader
* Marc Rehlinghaus
* Michèle J Hoffmann
* Günter Niegisch
* Annemarie Uhlig
* Lutz Trojan
* Julie Steinestel
* Konrad Steinestel
* Ralph M Wirtz
* Danijel Sikic
* Markus Eckstein
* Glen Kristiansen
* Marieta Toma
* Michael Hölzel
* Manuel Ritter
* Sebastian Strieth
* Jörg Ellinger
* Dimo Dietrich